Navigation Links
Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01

ProductsUltrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
Company ALPCO Diagnostics
Item Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
Features 
Description Qualitative and quantitative evaluation of pancreatic -cell function is not only of use in the pre- and post-diagnostic study of the natural history of diabetes mellitus, but is also relevant in clinical practice as a guide to the correct choice of treatment. Peripheral insulin levels cannot be used to assess -cell function because of the large and variable uptake from the portal circulation into the liver, and because insulin assays cannot distinguish endogenous from exogenous insulin1,3. Human C-peptide is a 31 amino acid chain with a molecular mass of approximately 3020 daltons. Within the pancreatic -cell, proinsulin is cleaved into one molecule of C-peptide and one molecule of insulin. C-peptide is subsequently released into the circulation at concentrations equimolar to those of insulin. In contrast to insulin, C-peptide is only minimally extracted by the liver. Peripheral C-peptide concentrations therefore reflect the secretion of -cells more accurately than insulin2,4 The ALPCO C-peptide ELISA is a solid phase two-site enzyme immunoassay. It is based on the direct sandwich technique in which two monoclonal antibodies are directed against separate antigenic determinants on the C-peptide molecule. During incubation, C-peptide in the sample reacts with peroxidase-conjugated anti-C-peptide antibodies and anti-C-peptide antibodies bound to microplate wells. A simple washing step removes unbound enzyme labeled antibody. The bound conjugate is detected by reaction with 3,3',5,5'-tetramethylbenzidine (TMB). The reaction is stopped by adding acid. The colorimetric endpoint is read spectrophotometrically.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. Insulin Ultrasensitive EIA Diabetes and Obesity Markers 008-10-1132-01
2. Ultrasensitive TSH EIA Thyroid Function 025-BC-1003
3. Hepatitis B Virus DNA Ultrasensitive Quantitative Real-Time PCR
4. HIV-1 Quantitative PCR with Reflex to HIV-1 Ultrasensitive Quantitative PCR
5. HIV-1 Ultrasensitive Quantitation by PCR
6. Human Immunodeficiency Virus 1 RNA Quantitative PCR with Reflex to Ultrasensitive RNA Quantitative PCR
7. Human Immunodeficiency Virus 1 Ultrasensitive RNA Quantitative PCR
8. Human Immunodeficiency Virus 1 Ultrasensitive Quantitative PCR with Reflex to HIV Quantitative PCR
9. Prostate Specific Antigen, Ultrasensitive
10. Thyroid Stimulating Hormone Ultrasensitive
11. C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
... power table has everything that you need ... new AIT-15 offers 20 mm of additional ... and locking castors to secure the table. ... for most any application. Use a double ...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... all-metal Trial Frame that is durably constructed, ... design that extends the life of the ... of springs and other components. The leaf ... comfortably on the patients head. The Trial ...
Inquire...
Medicine Products:
(Date:7/29/2014)... July 29, 2014 PeopleKeys today announced ... to teach students how to train and certify others ... Certified Behavioral Consultant Trainer , will be taught by ... of Training John Schindell as a live Tele-course over ... , The Certified Behavioral Consultant Trainer course will use ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, Auberge ... experience. The top of each luxurious resort bed is adorned ... expertly crafted, 100% Egyptian cotton white duvets and pillow shams ... closer look, words are woven in the linens that serve ... , Intentional breathing and visualization are keys to relaxing ...
(Date:7/29/2014)... Septic tanks have a ... score reflects a buyer's moderate ability to negotiate lower ... suppliers, the product's widespread availability and the price-competitive nature ... Weinstein. IBISWorld estimates that there are more than 400 ... supplier options. However, recent demand growth and rising costs ...
(Date:7/29/2014)... 29, 2014 The Marietta cosmetic dentists ... teeth whitening for high school and college students heading ... The teeth whitening is a safe, professional strength system, as ... confidence for students at these important stages in life. , ... have never had their teeth whitened. "After braces, teeth ...
(Date:7/28/2014)... 2014 NAPW honors ... Hospital Center, as a 2014 Professional Woman of the ... for leadership in community health. As the largest, most-recognized ... every industry and profession, the National Association of Professional ... over 600,000 members and nearly 300 Local Chapters. , ...
Breaking Medicine News(10 mins):Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Back to School Teeth Whitening Extravaganza For High School Students and Collegiates During August 2014 2Health News:Back to School Teeth Whitening Extravaganza For High School Students and Collegiates During August 2014 3Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2
... MNKD ), focused on discovering, developing and commercializing,treatments for ... following conferences: * The Acumen BioFin Rodman & Renshaw ... 6, 2007 at 2:20 PM ET at the New York ... * The CIBC 18th Annual Healthcare Conference on Wednesday November ...
... OTTR ) announced financial results for the quarter,ended September 30, ... of $302.2 million. -- Consolidated net income of $13.3 million ... with $13.5 million for the third quarter of 2006. -- ... 2007 compared with $0.45 for the third ...
... the inventor,of Pulse CO-Oximetry and Read-Through Motion and ... system-wide implementation of,Masimo SET pulse oximetry. Building on ... other areas of its network, CHN expanded the,adoption ... every site --,making Masimo SET CHN,s standard of ...
... retention, employee,engagement and retirement top the list of ... the Best Practices, LLC,s Global Benchmarking,Council. From executive-driven ... events, roundtable discussions and,information exchange teleconferences, proactive HR ... this year. As the year comes to ...
... ORLANDO, Fla., Nov. 1 The following is being,issued by Itamar Medical:, WHO: ... Rochester, MN ... Goteborg, Sweden ... Dr. Mark Pritzker, Cardiologist, ...
... Mass., Nov. 1, 2007 Researchers from the University of ... type 1 diabetes with dual grants from the Juvenile ... , The grants, which total $300,000, will support the ... Directed by Aldo A. Rossini, MD, the William and ...
Cached Medicine News:Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 2Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 3Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 4Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 5Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 6Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 7Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 8Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 9Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 10Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 11Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 12Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 13Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 14Health News:Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend 15Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Retain Talent and Engage Employees in 2008 2Health News:How Early Can We Detect Cardiovascular Disease Less Expensively... Even in Childhood? 'PAT' is the Invisible Signal 2Health News:UMass Medical School receives $300,000 from JDRF and Iacocca Foundation 2
(Date:7/28/2014)... 28, 2014  MiMedx Group, Inc. (NASDAQ: MDXG ), ... biomaterials and bioimplants processed from human amniotic membrane, announced today ... Highlights include: , Revenue exceeds upper ... to $25.6 million , Quarter-over-quarter revenue ... revenue increases 181% over Q2 2013 and 40% sequentially over ...
(Date:7/28/2014)... Calif. , July 28, 2014 KaloBios ... an update on the status of the KB001-A development ... Sanofi Pasteur.  KB001-A Collaboration Update ... agreement with Sanofi Pasteur to regain all rights to ... licensing agreement entered into in 2010 has been terminated. ...
(Date:7/28/2014)... , July 28, 2014 Reportlinker.com announces ... in its catalogue: Portugal Pharmaceuticals ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes ... View: Faster-than-expected economic growth last quarter has led ... slightly upwards. As forecast previously, BMI expects ...
Breaking Medicine Technology:MiMedx Announces Record Second Quarter Results 2MiMedx Announces Record Second Quarter Results 3MiMedx Announces Record Second Quarter Results 4MiMedx Announces Record Second Quarter Results 5MiMedx Announces Record Second Quarter Results 6MiMedx Announces Record Second Quarter Results 7MiMedx Announces Record Second Quarter Results 8MiMedx Announces Record Second Quarter Results 9MiMedx Announces Record Second Quarter Results 10MiMedx Announces Record Second Quarter Results 11MiMedx Announces Record Second Quarter Results 12MiMedx Announces Record Second Quarter Results 13MiMedx Announces Record Second Quarter Results 14MiMedx Announces Record Second Quarter Results 15MiMedx Announces Record Second Quarter Results 16MiMedx Announces Record Second Quarter Results 17MiMedx Announces Record Second Quarter Results 18KaloBios Provides Update on KB001-A Partnership and Clinical Status 2KaloBios Provides Update on KB001-A Partnership and Clinical Status 3KaloBios Provides Update on KB001-A Partnership and Clinical Status 4KaloBios Provides Update on KB001-A Partnership and Clinical Status 5KaloBios Provides Update on KB001-A Partnership and Clinical Status 6Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4